AUP.TO - Aurinia Pharmaceuticals Stock Price - Barchart.com 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.

Mar 04, 2020 · Aurinia Pharmaceuticals Inc stock is higher by 183.87% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives AUPH stock a score of 73 out of a possible 100.. That rank is influenced by a short-term technical score of 97. AUPH's rank also includes a long-term technical score of 94. Aurinia Prices US$166.7 Million Public Offering of Common ... Dec 10, 2019 · Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced the pricing of its underwritten public offering of … AUPH - Aurinia Pharmaceuticals Inc • BioPharmCatalyst Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH, TSX:AUP) ("Aurinia" or the "Company"), a late- stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that it has. 06 September 2019 Aurinia Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference

Aurinia Pharmaceuticals Inc. Current Price $14.97 Pharma stocks like Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) are coming into their own, offering growth 

Mar 04, 2020 · Aurinia Pharmaceuticals Inc stock is higher by 183.87% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives AUPH stock a score of 73 out of a possible 100.. That rank is influenced by a short-term technical score of 97. AUPH's rank also includes a long-term technical score of 94. Aurinia Prices US$166.7 Million Public Offering of Common ... Dec 10, 2019 · Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced the pricing of its underwritten public offering of … AUPH - Aurinia Pharmaceuticals Inc • BioPharmCatalyst Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH, TSX:AUP) ("Aurinia" or the "Company"), a late- stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that it has. 06 September 2019 Aurinia Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference Aurinia Issues Letter to Shareholders :: Aurinia ...

(NASDAQ:AUPH) (TSX:AUP) ("Aurinia" or the "Company"), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple 

9 Dec 2019 VICTORIA, British Columbia — Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) ( TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical  AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ©2020 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed 

View detailed stock price information for Aurinia Pharmaceuticals Inc. [AUP] from TMXmoney TSX Exchange | Apr 7, 2020, 7:33 PM EDT | Real-time price. logo.

AUP | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. AUP Stock Price, Forecast & News (Aurinia Pharmaceuticals)

Aurinia Pharmaceuticals Inc. [AUP] | Aurinia ...

5 Dec 2019 Shares of Aurinia Pharmaceuticals traded much higher after it company Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ; AUP:TSX), which is The stock established a new 52-week high price of US$17.48 this morning. 5 Feb 2013 5, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) Inc. trades on the Toronto Stock Exchange under the symbol "ISA". 13 Sep 2019 WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (“Aurinia” or Aurinia has also filed a prospectus supplement with securities in the United States through Nasdaq or another exchange at market prices. No sales will be conducted in Canada or through the Toronto Stock Exchange. 9 Dec 2019 VICTORIA, British Columbia — Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) ( TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical 

Aurinia Pharmaceuticals Inc. (AUPH) Aurinia Pharmaceuticals Initiates Rolling Submission of a New Drug Application to the U.S. Food and Drug Administration for Voclosporin in the Treatment of … Aurinia Pharmaceuticals (TSX:AUP) - Share price, News ... Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutic drugs for the treatment of various diseases in the United States and China. Aurinia Pharm Ord (AUPH-Q) Quote - The Globe and Mail Detailed price information for Aurinia Pharm Ord (AUPH-Q) from The Globe and Mail including charting and trades. from The Globe and Mail including charting and trades. (TSX:AUP) ("Aurinia AUP Stock Price and Chart — TSX:AUP — TradingView